UNSPSC 51421503: Loteprednol

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8CBU6KR16. European Medicines Agency schedules Loteprednol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08599MIG. Loteprednol generally arises in the molecular formula C21H27CLO5.

UNSPSC 51421503 Loteprednol is a Commodity code for a specific corticosteroid ophthalmic pharmaceutical, yet the sole recent state and local opportunity on record is a mismatch: Seminole County, Florida's IFB for naloxone and drug deactivation systems, posted June 30, 2026, does not involve loteprednol at all. The code shows no relevant recent solicitation activity aligned with its nominal pharmaceutical scope. State and local procurement under this Commodity appears dormant or is not being tagged to this code when it occurs.

Seminole County's naloxone procurement—1,900 units annually with 800 safe drug deactivation systems, quarterly deliveries, IFB due July 26, 2023—demonstrates that public health agencies do buy emergency pharmaceutical supplies, but the mismatch between the loteprednol code and the actual opportunity precludes meaningful characterization of issuing-body mix, geographic concentration, or market activity under this specific code. Vendors considering pursuit should verify whether state and local health departments, school districts, or other public bodies are issuing loteprednol solicitations under alternate codes or through cooperative purchasing agreements, as the current activity signal under 51421503 is insufficient to support a procurement strategy.